Profil
Sarit Steinberg is a Partner at Israel Biotech Fund since 2015.
Prior to this, she worked as the General Counsel at Immune Pharmaceuticals Ltd. from 2013 to 2015.
Ms. Steinberg holds a graduate degree from the London School of Economics & Political Science (2003) and a graduate degree from Queen Mary University of London (2002).
Postes actifs de Steinberg Sarit
| Sociétés | Poste | Début |
|---|---|---|
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Directeur des opérations | 01/02/2020 |
Anciens postes connus de Steinberg Sarit
| Sociétés | Poste | Fin |
|---|---|---|
Immune Pharmaceuticals Ltd.
Immune Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Conseiller Juridique Général | 01/05/2015 |
Formation de Steinberg Sarit
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Pharmaceuticals Ltd.
Immune Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Queen Mary University of London
Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
















